Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Other financing activities (2016 - 2024)

Historic Other financing activities for Tandem Diabetes Care (TNDM) over the last 4 years, with Q1 2024 value amounting to $183000.0.

  • Tandem Diabetes Care's Other financing activities changed N/A to $183000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $183000.0, marking a year-over-year increase of 35774.65%. This contributed to the annual value of $183000.0 for FY2024, which is 35774.65% up from last year.
  • Tandem Diabetes Care's Other financing activities amounted to $183000.0 in Q1 2024.
  • Over the past 5 years, Tandem Diabetes Care's Other financing activities peaked at $183000.0 during Q1 2024, and registered a low of -$405000.0 during Q3 2022.
  • For the 3-year period, Tandem Diabetes Care's Other financing activities averaged around -$52500.0, with its median value being $6000.0 (2022).
  • Over the last 5 years, Tandem Diabetes Care's Other financing activities had its largest YoY gain of 8246.91% in 2023, and its largest YoY loss of 8246.91% in 2023.
  • Quarter analysis of 3 years shows Tandem Diabetes Care's Other financing activities stood at $83000.0 in 2022, then crashed by 185.54% to -$71000.0 in 2023, then soared by 357.75% to $183000.0 in 2024.
  • Its Other financing activities was $183000.0 in Q1 2024, compared to -$71000.0 in Q3 2023 and $83000.0 in Q4 2022.